ABVD方案治疗失败后，采用MOPP方案治疗难治性霍奇金淋巴瘤。
MOPP treatment of resistant Hodgkin's disease following ABVD failure.
作者信息
Cimino G, Anselmo A P, Marzullo A, Maurizi Enrici R, Mauro F, Papa G, Mandelli F
出版信息
Tumori. 1983 Oct 31;69(5):469-72. doi: 10.1177/030089168306900516.
PMID:6196891
Abstract
Fourteen patients with Hodgkin's disease resistant to ABVD were treated with MOPP chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone). Complete remission was obtained in 6 patients (43%). Four of the 6 complete responders are disease free after 5, 20, 23, 35 months. The actuarial median survival after MOPP of all patients is 20 months. These data confirm that there is no "cross-resistance" among the drugs included in the two schedules.
摘要
14例对ABVD耐药的霍奇金病患者接受了MOPP化疗（氮芥、长春新碱、丙卡巴肼、泼尼松）。6例患者（43%）获得完全缓解。6例完全缓解者中有4例在5、20、23、35个月后无疾病。所有患者MOPP治疗后的精算中位生存期为20个月。这些数据证实这两种化疗方案中的药物之间不存在“交叉耐药”。
相似文献
1
MOPP treatment of resistant Hodgkin's disease following ABVD failure.ABVD方案治疗失败后，采用MOPP方案治疗难治性霍奇金淋巴瘤。
Tumori. 1983 Oct 31;69(5):469-72. doi: 10.1177/030089168306900516.
2
3
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.ABVD方案与MOPP/ABV混合方案治疗晚期霍奇金淋巴瘤的随机对照研究：一项多组间试验报告
J Clin Oncol. 2003 Feb 15;21(4):607-14. doi: 10.1200/JCO.2003.12.086.
4
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).用阿霉素、博来霉素、长春花碱和达卡巴嗪（ABVD）治疗后，MOPP耐药的霍奇金病患者获得长期无病生存。
Cancer Chemother Pharmacol. 1979;2(2):101-5. doi: 10.1007/BF00254081.
5
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.在MOPP疗法失败后，使用阿霉素、博来霉素、长春花碱和咪唑甲酰胺（ABVD）治疗晚期霍奇金病。
Cancer. 1978 Jun;41(6):2107-11. doi: 10.1002/1097-0142(197806)41:6<2107::aid-cncr2820410606>3.0.co;2-l.
6
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.霍奇金淋巴瘤放疗失败后的挽救性化疗：含阿霉素方案优于MOPP方案。
Cancer Treat Rep. 1986 Mar;70(3):343-8.
7
Can MOPP be replaced in the treatment of advanced Hodgkin's disease?在晚期霍奇金病的治疗中，MOPP方案能否被替代？
Semin Oncol. 1990 Feb;17(1 Suppl 2):2-6.
8
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!晚期霍奇金淋巴瘤：阿霉素、博来霉素、长春花碱和达卡巴嗪联合化疗方案（ABVD）疗效更佳，但仍不尽人意！
J Clin Oncol. 2003 Feb 15;21(4):583-5. doi: 10.1200/JCO.2003.11.072.
9
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Eur J Cancer Clin Oncol. 1982 Sep;18(9):803-6. doi: 10.1016/0277-5379(82)90188-2.
10
Pediatric Hodgkin's disease.小儿霍奇金病
J Ky Med Assoc. 2004 Mar;102(3):104-6.
引用本文的文献
1
Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.单胺氧化酶A在经典型霍奇金淋巴瘤中高表达。
J Pathol. 2017 Oct;243(2):220-229. doi: 10.1002/path.4944. Epub 2017 Sep 5.
Zotero 插件